RadNet - RDNT Forward P/S Multiple

Corporate emblem and logo of RadNet, Inc. (RDNT)

The forward P/S ratio on GURU.Markets helps evaluate the business value of RadNet, Inc. (RDNT) based on the scale of its outpatient MRI and CT center network in the US. Leadership in diagnostics and the implementation of AI ensure a steady patient flow. Recession resilience and expanding margins confirm the defensive qualities of the assets. Meanwhile, 2.50 captures the current value of the indicator, eliminating time lags between reports.

RDNT (RadNet Inc) Price to Expected Revenue Ratio history from 07/04/2022 to 11/13/2026

Analytical breakdowns for RadNet, Inc.

- market price and analyst price targets:
Price Chart RadNet|RDNT - Broker Consensus Forecast
- issuer market value details:
Market Capitalization RadNet Management|RDNT - Total Enterprise Value
- issuer book value statistics:
Accounting Value per Share RadNet|RDNT - Total Net Assets|Market Cap to Net Assets Ratio radnet.com|RDNT - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital RadNet, Inc.|RDNT - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity RadNet, Inc.|RDNT - Company Aggregate Debt|Debts to Book Capitalization RadNet Management|RDNT - Company Long-Term Liabilities|Company Current Liabilities RadNet|Quick Liquidity radnet.com
- net income and valuation multiples indicators:
RDNT - Final Profit|Projected Future Earnings RadNet, Inc.|RDNT - Price to Earnings Multiple|Future Price to Earnings RadNet Corp|RDNT - Growth-Adjusted P/E Ratio|Enterprise Value to EBITDA Ratio RadNet Management|RDNT - Company profit before taxes, interest and amortization|Net earnings per share for the last 12 months RadNet|RDNT - Earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months radnet.com|RDNT - Earnings per share increase in current year|Earnings growth forecast for next year RadNet, Inc.
- issuer revenue and sales details:
RDNT - Company Total Revenue|Projected Sales Volume RadNet|RDNT - P/S Multiple|Forward Price-to-Revenue Multiple RadNet Management
Fundamental company valuation:RadNet RDNT
Product sample of RadNet, Inc.

The integration of ESG standards and the digitalization of diagnostics at RadNet, Inc. (RDNT) optimize operating expenses, which directly impacts future revenue. This ratio compares market capitalization with projected earnings, allowing for an assessment of the extent to which the business value is inflated relative to profit growth rates; therefore, extreme values of the forward P/S indicator signal either that the asset is overbought or that its fundamental base is degrading.

Competitors of RadNet, Inc. (RDNT)

Price-to-Projected Revenue Ratio HCA Healthcare HCA|THC: Market Cap to Projected Revenue|Fresenius Medical Care Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Solventum Health|EHC (Encompass Health) - Forward Price-to-Revenue Multiple|UHS: Price to Expected Revenue Ratio|Forward Price-to-Revenue Multiple DVA|OPCH: Forward Price to Sales|Forward P/S Multiple SGRY|Market Cap to Expected Sales Ratio Premier Health|Price-to-Projected Revenue Ratio National Vision Holdings EYE|PGNY: Market Cap to Projected Revenue|Ardent Health Partners - Forward P/S Multiple|Select Medical Corporation (SEM) - Forward Price-to-Revenue Multiple|ASTH (Apollo Medical Holdings) - Forward Price-to-Revenue Multiple|MD - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio US Physical Therapy|PNTG: Forward Price to Sales|Forward P/S Multiple ORGO|Nutex Health Inc - Market Cap to Projected Revenue|Price-to-Projected Revenue Ratio Auna Health AUNA|SBC: Market Cap to Projected Revenue|EOLS: Forward Price-to-Revenue Multiple|chs.net - Price to Expected Revenue Ratio|SKIN (beautyhealth.com) - Forward Price-to-Revenue Multiple|MDWD: Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio Biote Corp|JYNT: Forward Price to Sales|Forward P/S Multiple DCGO|PIII - Market Cap to Future Revenue Ratio|Forward P/S Multiple GANX (Gain Therapeutics)|Forward P/S Multiple EUDA Health Holdings EUDA|BMGL: Forward Price-to-Revenue Multiple|CollPlant Biotechnologies - Price to Expected Revenue Ratio|Cuprina Holdings (Cayman) Ltd (CUPR) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple concordmedical.com|AMS (American Shared Hospital Services) - Forward P/S Multiple|Market Cap to Future Revenue Ratio MEDIROM Healthcare Group Inc. MRM|Price-to-Projected Revenue Ratio Avalon GloboCare (ALBT)|DIH Group - Market Cap to Projected Revenue|Longevity Health Holdings - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio NIVF (newgenivf.com)|ATIP - Price-to-Projected Revenue Ratio|Forward Price to Sales CMAX (CareMax Inc.)|KDLY: Forward P/S Multiple|ModivCare Corp (MODV) - Forward P/S Multiple|NVOS (Novo Integrated Sciences) - Forward P/S Multiple|Market Cap to Projected Revenue SSY (SunLink Health Systems, Inc)|Price-to-Projected Revenue Ratio IMAC Holdings (BACK)